DRKS00029116进行中（未招募）不适用
Prospective study to demonstrate safety and usability as well as a positive healthcare effect in the domestic use of the PleurX Drainage Minikit for the drainage of pleural effusions and ascites - DRAIN-FAST
Becton Dickinson0 个研究点目标入组 7 人开始时间: 2022年11月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Medically diagnosed benign or malignant pleural effusion or ascites with indication for drainage by the PleurX Drainage Minikit.
- •2. Patient must be able to be discharged to the home environment after catheter has been implanted
- •3. Age: at least 18 years
- •4. Patients must be able to understand patient information
- •5. Patients must be willing and able to meet the requirements of the study
- •6. Signed declaration of informed consent
排除标准
- •1. Patients with a life expectancy < 2 months (doctor's assessment)
- •2. Patients with planned hospital stays
- •3. Patients with problems/inflammations at the catheter exit point
研究者
相似试验
招募中
2 期
Anti-chlamydophila antibiotic combination therapy in the treatment of patients with Coronary Heart DiseaseChlamydophila pneumoniae infectionCardiovascular - Coronary heart diseaseInfection - Other infectious diseasesCoronary Heart DiseaseACTRN12618000260224Centre for Digestive Diseases60
已完成
不适用
Pilot study for a new oral immunotherapy for peanut allergyPeanut allergyInflammatory and Immune System - AllergiesACTRN12614000919617Dr Billy Tao15
已完成
不适用
Safety and performance of Saluda Medical's EvokeTM with feedback control in patients with chronic pain to treat their upper or lower limb paichronic upper and lower limb painAnaesthesiology - Pain managementNeurological - Other neurological disordersSurgery - Other surgeryACTRN12615000713594Saluda Medical Pty Ltd70
未知
1 期
A prospective study which assess the safety and efficiacy of haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide for adult T cell leukemia/lymphomaaggressive adult T cell leukemia/lymphomaJPRN-UMIN000021783ational Cancer Center Hospital17
进行中（未招募）
1 期
Survival Prolongation by Rationale Innovative GenomicsPatients with advanced/metastatic non-small cell lung cancer (NSCLC) with no documented targetable alterations (EGFR mutation, ALK translocation, ROS1 mutation if available or MET exon 14 skipping mutation if available)EUCTR2017-001455-32-FRWorldwide Innovative Network Association130